Stockscreener 앱 받기
34.05
0.12%
-0.04
시간 외 거래:
34.05
전일 마감가:
$34.09
열려 있는:
$34
하루 거래량:
527.94K
Relative Volume:
0.77
시가총액:
$1.74B
수익:
$681.88M
순이익/손실:
$122.63M
주가수익비율:
16.14
EPS:
2.11
순현금흐름:
$220.18M
1주 성능:
+12.30%
1개월 성능:
+17.13%
6개월 성능:
-5.63%
1년 성능:
+8.86%
1일 변동 폭
$33.70
$34.50
1주일 범위
$29.82
$34.50
52주 변동 폭
$26.47
$41.61
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.05 | 1.74B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-12-17 | 개시 | H.C. Wainwright | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-10 | 개시 | UBS | Buy |
| 2024-06-21 | 개시 | Citigroup | Buy |
| 2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-20 | 개시 | BofA Securities | Neutral |
| 2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
| 2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-04 | 개시 | Raymond James | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-14 | 개시 | Goldman | Neutral |
| 2020-09-14 | 개시 | Jefferies | Buy |
| 2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigationHRMY - ACCESS Newswire
Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Harmony Biosciences (HRMY) Maintains "Buy" Rating with $49 Price Target | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Hi - GuruFocus
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Results - TipRanks
Harmony Biosciences Reports Strong Earnings and Growth - TipRanks
Harmony Biosciences Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences reports Q1 EPS $1.03, consensus 91c - TipRanks
Harmony Biosciences Q1 2025 Earnings Call Transcript - MarketBeat
Harmony (HRMY) Reports Increase in Cash and Investments | HRMY S - GuruFocus
Harmony Biosciences (HRMY) Receives Buy Rating Reiteration by Ne - GuruFocus
Harmony Biosciences Q1 Adjusted Earnings, Revenue Increase; 2025 Sales Outlook Reiterated - marketscreener.com
Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (13 Ratings) - Benzinga
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Harmony Biosciences Q1 2025 Earnings: EPS of $0.78 and Revenue o - GuruFocus
Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView
Harmony Biosciences (HRMY) Reports Q1 Revenue Surpassing Expectations | HRMY Stock News - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Hi - GuruFocus
Harmony Biosciences Holdings, Inc Q1 Profit Increases, Beats Estimates - Nasdaq
Harmony Biosciences stock surges 5% on strong Q1 earnings beat By Investing.com - Investing.com Canada
Harmony Biosciences stock surges 5% on strong Q1 earnings beat - Investing.com Australia
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance ? | HRMY Stock News - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance - marketscreener.com
Earnings Flash (HRMY) Harmony Biosciences Holdings Reports Q1 Adjusted EPS $1.03 - marketscreener.com
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance - Business Wire
Harmony Biosciences to Report First Quarter 2025 Financial Resul - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus
Raymond James Financial Inc. Makes New $1.30 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Wells Fargo & Company MN Reduces Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings Inc expected to post earnings of 59 cents a shareEarnings Preview - TradingView
(HRMY) Trading Signals - news.stocktradersdaily.com
HC Wainwright Has Negative Outlook for HRMY Q1 Earnings - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of “Buy” from Analysts - Defense World
Why Harmony Biosciences (HRMY) Could Beat Earnings Estimates Again - Yahoo Finance
H.C. Wainwright maintains $70 target on Harmony Biosciences stock By Investing.com - Investing.com India
Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025 - BioSpace
H.C. Wainwright maintains $70 target on Harmony Biosciences stock - Investing.com Australia
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
UBS Adjusts Price Target for Harmony Biosciences (HRMY) | HRMY S - GuruFocus
UBS Adjusts Price Target on Harmony Biosciences to $48 From $55, Maintains Buy Rating - marketscreener.com
Envestnet Asset Management Inc. Purchases 1,321 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Harmony Biosciences (HRMY) Projected to Post Earnings on Tuesday - Defense World
First Week of June 20th Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Is Weakness In Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - simplywall.st
BofA Cuts Price Target on Harmony Biosciences to $32 From $33 - marketscreener.com
Harmony Biosciences (HRMY) Faces Revised Price Target Amid Q1 Ch - GuruFocus
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.84%
0.15%
자본화:
|
볼륨(24시간):